Business Context and Reporting Period
This Form 8-K is a current report filed by Eyenovia, Inc. (not Hyperion DeFi, Inc.) on June 7, 2022. The registrant is a Delaware corporation with its principal executive offices in New York, NY, and its common stock trades on the Nasdaq Capital Market under the symbol EYEN. The company is classified as an emerging growth company.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. No financial metrics are provided in this document.
Material Changes
The filing reports a significant change in executive leadership under Item 8.01 (Other Events):
- Dr. Tsontcho (Sean) Ianchulev, the company's co-founder, Chief Medical Officer, and Chief Executive Officer, will step down as CEO.
- He will transition to the role of non-executive Chairman of the Board of Directors.
- The definitive timeline for this transition is to be determined over the weeks following the report date.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary regarding future performance. The primary risk disclosed is the operational impact of the CEO transition, though the specific timeline remains undetermined. No unusual items or contingencies are detailed in this report.
Investor Verification Checklist
- Verify the exact timeline for the CEO transition and the appointment of a successor CEO.
- Review the full text of the press release filed as Exhibit 99.1 for additional context on the leadership change.
- Confirm the continued role of Dr. Ianchulev as Chief Medical Officer and non-executive Chairman.
- Check subsequent filings for the appointment of a new CEO.